Bladder cancer (BC) is the 10th most frequent cancer in the world. The initial diagnosis and
surveillance of BC require a combination of invasive and non-invasive methods, which are …

Bladder cancer (BC) is a potentially life‑threatening malignancy. Due to a high recurrence
rate, frequent surveillance strategies and intravesical drug therapies, BC is considered one …

Background Little is known about the unmet supportive care needs of patients affected by
muscle invasive bladder cancer (MIBC). We set out to determine the different domains of …

Objective. To investigate the expression of kinesin family member 20A (KIF20A) in bladder
cancer, the effect of KIF20A on the proliferation and metastasis of bladder cancer cells, and …

Precision medicine is designed to tailor treatments for individual patients by factoring in
each person's specific biology and mechanism of disease. This paradigm shifted from a “one …

Background: Ras-related C3 botulinum toxin substrate 3 (Rac3) is overexpressed in
malignancies and promotes tumor progression. However, the correlations between Rac3 …

The objectives of this study are to evaluate if robotic cystectomy demonstrates reduced
complications, readmissions, and cost-to-patient compared to open approach 30-day post …

Despite the great scientific advances that have been made in cancer treatment, there is still
much to do, particularly with regard to urinary bladder cancer. Some of the drugs used in …

In recent researches, high expression of nesfatin‐1/nucleobindin‐2 (NUCB2) is linked to
poor prognosis in prostate and colon cancer due to the enhancement in proliferation …

Introduction Bladder cancer is the most frequently occurring tumour of the urinary system.
Ta, T1 tumours and carcinoma in situ (CIS) are grouped as non-muscle invasive bladder …